Major Ingredients

Each Tablet Contains Deflazacort INN 6mg.

Major Functionality

It is indicated for the treatment of a variety of inflammatory conditions including: Duchenne muscular dystrophy (DMD) in patients 5 years of age and older, Severe allergic reactions, e.g. anaphylaxis, Asthma, Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica, Inflammatory bowel disease such as Crohn's disease and ulcerative colitis, Inflammatory disorders of the kidney, such as nephritic syndrome and interstitial nephritis,Inflammatory eye disorders, e.g. uveitis, optic neuritis, Inflammatory skin disorders, including pemphigus vularis, bullous pemphigoid and pyoderma gangrenosum, Inflammatory disease of the skin and muscles (dermatomyositis), Systemic lupus erythematosus, Mixed connective tissue disease, Rare condition involving inflammation in the walls of arteries (polyarteritis nodosa), Sarcoidosis, Rheumatic carditis, Cancer of the bone marrow (multiple myeloma), Acute and lymphatic leukaemia, Cancer of the lymph nodes (lymphoma), Idiopathic thrombocytopenic purpura, Anaemia caused by the immune system attacking red blood cells (autoimmune haemolytic anaemia) Helping to prevent the immune system attacking a transplanted organ, e.g. heart, liver, kidney etc.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.